[1]
Carrasco, J.L. et al. 2013. A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain. Actas Españolas de Psiquiatría. 41, 3 (May 2013), 164–174.